Header Logo

Mohit Chopra

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
81
0.690
 Why?
Depressive Disorder
3
2009
284
0.680
 Why?
Stress Disorders, Post-Traumatic
3
2016
404
0.680
 Why?
Opioid-Related Disorders
5
2025
524
0.560
 Why?
Memantine
3
2014
22
0.550
 Why?
Methadone
3
2025
140
0.540
 Why?
Health Status
2
2016
448
0.460
 Why?
Excitatory Amino Acid Antagonists
2
2013
38
0.450
 Why?
Social Stigma
1
2016
74
0.450
 Why?
Obsessive-Compulsive Disorder
1
2011
35
0.350
 Why?
Benzodiazepines
1
2011
106
0.340
 Why?
Patient Acceptance of Health Care
1
2016
494
0.340
 Why?
Narcotics
2
2025
57
0.340
 Why?
Disulfiram
2
2025
5
0.310
 Why?
Alzheimer Disease
3
2014
761
0.300
 Why?
Quality of Life
2
2016
1256
0.300
 Why?
Apolipoprotein E4
1
2009
46
0.300
 Why?
Antipsychotic Agents
1
2011
302
0.290
 Why?
Methadyl Acetate
1
2008
1
0.290
 Why?
Reward
1
2009
89
0.290
 Why?
Psychiatric Status Rating Scales
2
2013
382
0.290
 Why?
Narcotic Antagonists
2
2014
132
0.280
 Why?
Naloxone
1
2008
53
0.280
 Why?
Buprenorphine
2
2014
197
0.260
 Why?
Aging
1
2013
761
0.260
 Why?
Cognition Disorders
1
2008
223
0.250
 Why?
Alcohol Deterrents
1
2025
6
0.230
 Why?
Dementia
1
2008
272
0.220
 Why?
Geriatric Assessment
1
2006
160
0.220
 Why?
Long-Term Care
1
2006
179
0.220
 Why?
Aged
12
2016
14872
0.210
 Why?
Male
19
2025
30894
0.210
 Why?
Opiate Substitution Treatment
3
2025
223
0.200
 Why?
Depression
3
2016
892
0.200
 Why?
Hallucinations
1
2003
17
0.200
 Why?
Female
18
2025
33853
0.190
 Why?
Vitamin E
2
2014
55
0.190
 Why?
Treatment Refusal
1
2003
57
0.190
 Why?
Mental Competency
1
2003
62
0.190
 Why?
Anxiety
3
2016
425
0.190
 Why?
Comorbidity
3
2016
1115
0.180
 Why?
Informed Consent
1
2003
141
0.180
 Why?
Antioxidants
2
2014
249
0.170
 Why?
Attitude to Health
1
2003
296
0.170
 Why?
Nursing Homes
1
2006
674
0.160
 Why?
Humans
21
2025
64908
0.160
 Why?
Decision Making
1
2003
415
0.150
 Why?
Double-Blind Method
6
2025
740
0.140
 Why?
Severity of Illness Index
5
2014
1557
0.130
 Why?
Veterans
3
2016
758
0.130
 Why?
Dose-Response Relationship, Drug
3
2025
852
0.130
 Why?
Cyclohexanecarboxylic Acids
1
2014
9
0.110
 Why?
Dopamine Agents
1
2014
11
0.100
 Why?
Amines
1
2014
31
0.100
 Why?
Sertraline
1
2014
58
0.100
 Why?
gamma-Aminobutyric Acid
1
2014
75
0.100
 Why?
Aged, 80 and over
4
2014
5576
0.100
 Why?
Alcohol-Related Disorders
1
2013
37
0.090
 Why?
Alcoholism
1
2016
328
0.090
 Why?
Adult
8
2025
17282
0.090
 Why?
Longitudinal Studies
2
2013
1276
0.090
 Why?
Motivation
1
2014
295
0.090
 Why?
Disease Progression
2
2014
1213
0.090
 Why?
Combat Disorders
1
2011
11
0.090
 Why?
Patient Compliance
2
2014
365
0.090
 Why?
Activities of Daily Living
2
2014
293
0.080
 Why?
Life Change Events
1
2011
66
0.080
 Why?
Internet
1
2014
466
0.080
 Why?
Wounds and Injuries
1
2013
255
0.080
 Why?
Amphetamine-Related Disorders
1
2009
11
0.080
 Why?
Chronic Disease
1
2013
741
0.080
 Why?
Methamphetamine
1
2009
25
0.080
 Why?
Directive Counseling
1
2009
39
0.080
 Why?
Arkansas
1
2008
4
0.070
 Why?
Benzhydryl Compounds
1
2009
61
0.070
 Why?
Logistic Models
2
2011
1269
0.070
 Why?
Cocaine
2
2025
101
0.070
 Why?
Secondary Prevention
1
2009
164
0.070
 Why?
United States
3
2013
8067
0.070
 Why?
Self Concept
1
2008
118
0.070
 Why?
Paroxetine
2
2004
16
0.070
 Why?
Substance Withdrawal Syndrome
1
2008
126
0.060
 Why?
Middle Aged
6
2025
18166
0.060
 Why?
Sex Characteristics
1
2008
211
0.060
 Why?
Neuropsychological Tests
1
2008
409
0.060
 Why?
Psychometrics
1
2008
392
0.060
 Why?
Multivariate Analysis
1
2008
929
0.060
 Why?
Mental Health Services
2
2011
300
0.060
 Why?
Dysthymic Disorder
1
2005
8
0.060
 Why?
Psychotherapy
1
2006
102
0.060
 Why?
Mortality
1
2006
160
0.050
 Why?
Pindolol
1
2004
2
0.050
 Why?
Prolactin
1
2004
40
0.050
 Why?
Antidepressive Agents
1
2006
228
0.050
 Why?
Antidepressive Agents, Second-Generation
1
2004
30
0.050
 Why?
Tryptophan
1
2004
56
0.050
 Why?
Disability Evaluation
1
2005
216
0.050
 Why?
Treatment Outcome
3
2025
5774
0.050
 Why?
Combined Modality Therapy
2
2014
371
0.050
 Why?
Adrenergic beta-Antagonists
1
2004
152
0.050
 Why?
Hydrocortisone
1
2004
192
0.050
 Why?
Drug Therapy, Combination
2
2014
461
0.050
 Why?
Cross-Sectional Studies
2
2011
2697
0.050
 Why?
Surveys and Questionnaires
1
2008
2759
0.040
 Why?
Follow-Up Studies
1
2005
2483
0.040
 Why?
Primary Health Care
1
2005
718
0.040
 Why?
Adolescent
1
2009
6305
0.040
 Why?
Remission Induction
2
2011
149
0.030
 Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
118
0.030
 Why?
Retrospective Studies
1
2008
6831
0.030
 Why?
GABA Agonists
1
2014
4
0.030
 Why?
Diagnosis, Dual (Psychiatry)
1
2014
89
0.030
 Why?
Cross-Over Studies
2
2004
164
0.030
 Why?
Cholinesterase Inhibitors
1
2014
50
0.030
 Why?
Residence Characteristics
1
2014
233
0.020
 Why?
Medication Adherence
1
2014
198
0.020
 Why?
Recurrence
1
2014
655
0.020
 Why?
Risk Factors
2
2011
5407
0.020
 Why?
Caregivers
1
2014
292
0.020
 Why?
Analgesics, Opioid
1
2014
525
0.020
 Why?
Self Report
1
2010
391
0.020
 Why?
Sex Factors
1
2011
990
0.020
 Why?
Alcohol Drinking
1
2010
322
0.020
 Why?
Pilot Projects
1
2009
1010
0.010
 Why?
Mass Screening
1
2011
696
0.010
 Why?
Fluoxetine
1
2004
45
0.010
 Why?
Young Adult
1
2014
4784
0.010
 Why?
Drug Administration Schedule
1
2004
295
0.010
 Why?
Substance-Related Disorders
1
2011
750
0.010
 Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_